Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis.

MLA

Yosipovitch, Gil, et al. “Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis.” Dermatology & Therapy, vol. 11, no. 6, Dec. 2021, pp. 2147–57. EBSCOhost, https://doi.org/10.1007/s13555-021-00630-9.

APA

Yosipovitch, G., de Bruin-Weller, M., Armstrong, A., Wu, J. J., Herranz, P., Thaçi, D., Delevry, D., Bagousse, G. B.-L., Zhang, R., Shumel, B., Rossi, A. B., & Chao, J. (2021). Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatology & Therapy, 11(6), 2147–2157. https://doi.org/10.1007/s13555-021-00630-9

Chicago

Yosipovitch, Gil, Marjolein de Bruin-Weller, April Armstrong, Jashin J. Wu, Pedro Herranz, Diamant Thaçi, Dimittri Delevry, et al. 2021. “Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis.” Dermatology & Therapy 11 (6): 2147–57. doi:10.1007/s13555-021-00630-9.